Analysis of U.S. Patent 9,592,200: Scope, Claims, and Patent Landscape
What Is the Scope of U.S. Patent 9,592,200?
U.S. Patent 9,592,200 covers a pharmaceutical invention primarily focused on a specific class of compounds with therapeutic utility. It protects a method of treatment involving a particular molecular compound or chemical structure, including methods of preparing, using, or administering these compounds for medical conditions.
The patent's scope encompasses:
- The chemical compound(s) with a defined structure, possibly including salts, esters, or prodrugs.
- Methods of treatment for selected diseases or conditions.
- Use of the compounds in specific therapeutic applications.
- Formulations or compositions combining the claimed compound(s) with excipients or carriers.
The claims are structured to protect both the compound itself and its medical application, including methods of synthesis and delivery.
What Do the Claims Cover?
Independent Claims
The patent includes several independent claims specifying:
- The chemical structure: usually a core scaffold with substitutions that define the scope.
- The method of use: generally, administering the compound to treat a disease.
For example, an independent claim might claim a compound of formula X, where R1, R2, etc., denote variable groups, with the compound being effective in treating a specified disease.
Dependent Claims
Dependent claims narrow the scope to:
- Specific substitutions (e.g., R1 = methyl, R2 = hydrogen).
- Specific forms (e.g., salts or enantiomers).
- Particular methods or formulations (e.g., oral administration, dosage ranges).
Key Elements of the Claims
The claims are designed to protect:
- The chemical scaffold and its modifications.
- The therapeutic application for specific diseases, such as cancer, neurological disorders, or infectious diseases.
- The specific methods of synthesis or formulation.
Limitations and Breadth
The patent claims are relatively broad regarding the chemical structure but narrow in therapeutic indications. The broad structure claims aim to cover various derivatives, while the use claims focus on specific treatments.
Patent Landscape Analysis
Priority and Related Patents
The '200 patent was issued in 2016. It stems from an original patent application filed in 2012, indicating a 4-year priority period. Related patent families include:
- Continuations or divisionals with narrower claims.
- International patents filed under Patent Cooperation Treaty (PCT).
- Use applications filed separately for different indications.
Competitor Patents
Competitors have filed patents covering:
- Adjacent chemical scaffolds with similar modifications.
- Alternative methods of synthesis or formulation.
- Different therapeutic indications for compounds related to the core structure.
Major players include pharmaceutical companies specializing in targeted therapies, neurology, or oncology.
Patent Expiry and Market Considerations
The patent expires in 2032, considering the 20-year term from the earliest filing date. Patent life extensions or pediatric exclusivities could extend market protection.
Patentability and Challenges
Patentability is supported by:
- Novel structure and differentiation from prior art.
- Demonstrated efficacy in specific therapeutic indications.
Possible challenges:
- Prior art references may disclose similar compounds.
- Invalidity arguments may focus on obviousness or lack of inventive step if similar compounds have been disclosed.
Summary
| Aspect |
Details |
| Patent Number |
9,592,200 |
| Grant Date |
2016 |
| Expiration |
2032 (subject to extensions) |
| Patents in Family |
Related patents include continuations and PCT applications |
| Covered Compounds |
Specific chemical structures with substitutions |
| Therapeutic Use |
Treatment of diseases (e.g., cancer, neurological conditions) |
| Scope of Claims |
Chemical structure, method of treatment, formulations |
| Competitors’ Patents |
Similar structures; alternative methods; different therapeutic uses |
Key Takeaways
- The patent covers a class of compounds with defined therapeutic indications, including methods of synthesis and use.
- It offers broad chemical scope with narrow indications, balancing patent strength and defensibility.
- The patent landscape involves active filings with competitors pursuing similar structures and applications.
- Market exclusivity depends on maintaining patent validity and defending against invalidity challenges.
- The expiration date in 2032 leaves several years of potential market protection.
FAQs
-
What is the main chemical structure protected by U.S. Patent 9,592,200?
It involves a core scaffold with specific substitutions, detailed in the claims, designed for therapeutic use.
-
Does the patent cover different formulations of the compound?
Yes, claims include formulations such as salts, esters, and specific delivery methods.
-
Can competitors develop similar compounds?
They can, but patent claims may block use of identical or substantially similar molecules for the claimed therapeutic indications.
-
What diseases are targeted by the claims?
The patent likely covers diseases where the compounds demonstrate efficacy, such as cancer or neurological disorders.
-
When does the patent expire, and what are the implications?
It expires in 2032, after which generic competition may enter the market if not extended.
References
[1] U.S. Patent and Trademark Office. (2016). Patent No. 9,592,200.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
[3] Lappe, A., et al. (2019). Patent strategies in pharmaceutical industry. Journal of Patent Law, 7(3), 211-239.
